Bernardino
Miñana López
Consultor Médico
GlaxoSmithKline (Spain)
Madrid, EspañaPublicaciones en colaboración con investigadores/as de GlaxoSmithKline (Spain) (3)
2021
-
Real-world therapeutic management and evolution of patients with benign prostatic hyperplasia in primary care and urology in Spain
International Journal of Clinical Practice, Vol. 75, Núm. 8
2020
-
Real-world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain
International Journal of Clinical Practice, Vol. 74, Núm. 11
2009
-
The Influence of Baseline Parameters on Changes in International Prostate Symptom Score with Dutasteride, Tamsulosin, and Combination Therapy among Men with Symptomatic Benign Prostatic Hyperplasia and an Enlarged Prostate: 2-Year Data from the CombAT Study
European Urology, Vol. 55, Núm. 2, pp. 461-471